Neurocrine Biosciences announced the most recent outcome of research on their investigational medication for pediatric patients with epileptic encephalopathy with continuous spike-and-wave during sleep.
Read More
Airway Management’s flexTAP, a lab-made oral appliance to treat snoring and sleep apnea, will now be available through partner dental labs.
Read More
Poor quality sleep, including too much or too little, daytime sleepiness, and snoring, may be linked to a heightened risk of developing glaucoma, suggests a large UK Biobank study published in BMJ Open.
Read More
A drug in development for obstructive sleep apnea (OSA) has shown promising results after researchers from Flinders University tested the treatment in people for the first time.
Read More
A peer-reviewed study in Military Medicine found that 88% of obstructive sleep apnea (OSA) patients were successfully treated using oral appliances.
Read More